ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON, AND 2) DEVELOP ANTIBIOTICS FOR USE IN PUBLIC HEALTH AND BIOTHREAT EMERGEN
$26,185,459
| Recipient | MELINTA THERAPEUTICS, LLC UEI H8K6F2A4KD49 |
|---|---|
| Award ID | 75A50123C00022 |
| Award amount | $26,185,459 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN44 |
| Start date | Jul 6, 2023 |
| End date | Nov 20, 2025 |
| Place of performance | WASHINGTON, DC |
| Record updated | Sep 11, 2025 |
View the official award record
More awards won by MELINTA THERAPEUTICS, LLC
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $9,658,300 · Sep 1, 2024
BPA FOR REZZAYO
Department of Veterans Affairs · $500,000 · Apr 25, 2024
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids